Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2000
03/16/2000WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
03/16/2000WO1999051723A3 Bacterial transglutaminases
03/16/2000CA2343136A1 Diagnostic method for detecting disturbances of the pancreas
03/16/2000CA2342859A1 Production of human erythropoietin
03/16/2000CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341327A1 Novel protein and dna thereof
03/16/2000CA2341307A1 Antibody for detecting possibility of onset of bovine leukemia
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/15/2000EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein
03/15/2000EP0985053A1 Translational frameshift based drug screening assay
03/15/2000EP0985040A1 Preparation of glycosylated tumor necrosis factor
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985036A1 Zinc ring protein
03/15/2000EP0985033A2 Polyvalent and polyclonal libraries
03/15/2000EP0985032A1 RIBOSOME COMPLEXES AS SELECTION PARTICLES FOR $i(IN VITRO) DISPLAY AND EVOLUTION OF PROTEINS
03/15/2000EP0984986A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/15/2000EP0984703A2 Methods of producing protein hydrolysates
03/15/2000EP0723453B1 Method of treating reproductive disorders
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000EP0551325B1 Method of testing for salmonella
03/15/2000EP0541726B1 Growth factor compositions, preparation and use
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6
03/15/2000CN1247566A Novel peptide, novel DNA, and novel antibody
03/15/2000CN1247229A Paddy rice group of preventing rice blast
03/14/2000US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037454 Humanized anti-CD11a antibodies
03/14/2000US6037450 Genetically engineered binding polypeptide where carboxy terminal cysteine is replaced or is not palmitoylated; for the diagnosis and treatment of inflammation and autoimmune diseases; antiinflammatory agents
03/14/2000US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037163 Human microfibril-associated glycoprotein 4 splice variant
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037147 Nucleotide sequence coding electron transfer protein
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis
03/14/2000US6037125 Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
03/14/2000US6037119 Screening for modulators of enzyme activity; propagating cells transformed or transfected with nucleotide sequences coding guanosine monophosphate, preparing extracts, screening for modulators
03/14/2000CA2281935A1 Streptomyces avermitilis regulatory genes for increased avermectin production
03/14/2000CA2163081C Thermoresistant alpha-1-antitrypsin mutein
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2008817C M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
03/14/2000CA2006969C Polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide
03/14/2000CA1340926C Human rhinovirus peptides
03/14/2000CA1340924C Structural phosphoprotein (pp 150) of human cytomegalovirus, and the preparation thereof
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012727A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity
03/09/2000WO2000012723A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
03/09/2000WO2000012722A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them
03/09/2000WO2000012721A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012705A2 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000WO2000012704A2 Enhanced functional expression of g protein-coupled receptors
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012700A1 GENE ENCODING CDw108
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012561A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
03/09/2000WO2000012559A1 Monoclonal antibodies against s100
03/09/2000WO2000012558A1 Human monoclonal antibodies directed against the islet cell antigen ia-2
03/09/2000WO2000012556A1 High-affinity antibodies
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012140A1 Method for labeling biopolymers using isotopes
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000CA2343046A1 Enhanced functional expression of g protein-coupled receptors
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2340865A1 High-affinity antibodies
03/09/2000CA2340794A1 Protein transport-associated molecules
1 ... 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 ... 1125